Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a smartphone app for exposure therapy in anxiety disorders

Official title: Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders: a Randomized Controlled Trial Using a Mixed Methods Approach

Run by Universitat Jaume I · NCT06788119 · Data updated 2026-11-12

This study is testing whether using a smartphone app can make exposure therapy more effective for people with anxiety compared to traditional therapy alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment158 (estimated)
SponsorUniversitat Jaume I
Academic / other
Locations1 site (Castellon, Castellón)
StatusRecruiting
StartedApril 30, 2025
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedMay 16, 2025
Trial IDNCT06788119 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who meet the DSM-5 criteria for specific phobia, agoraphobia, panic disorder, or social anxiety disorder.

Probably not a fit

Patients with other psychological issues requiring immediate attention or those currently undergoing similar treatment programs may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and evaluate a novel smartphone-guided intervention called SYMPTOMS-JIT for in vivo exposure therapy in patients with anxiety disorders. It will compare the efficacy of traditional cognitive behavioral therapy (CBT) with in vivo exposure (IVE) against CBT with the added SYMPTOMS-JIT app. The study will assess treatment outcomes at multiple follow-up points to determine the effectiveness and patient preference for the app-enhanced therapy. Additionally, it will explore barriers to technology use in mental health treatment.

Why it matters

Potential benefit: If successful, this approach could enhance the effectiveness and accessibility of exposure therapy for patients with anxiety disorders.

How similar studies have gone: While the use of technology in mental health is growing, this specific approach of combining sensor-guided interventions with in vivo exposure therapy is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being at least 18 years or older.
* Meeting DSM-5 diagnostic criteria (APA, 2013) for anxiety disorder, specifically specific phobia, agoraphobia, panic disorder and social phobia.
* Being willing to follow the study conditions.
* Sign the consent form.

Exclusion Criteria:

* Having another psychological problem that requires immediate attention.
* Having current alcohol or drug dependence or abuse, psychosis or severe organic illness.
* Currently being treated in a similar treatment program.
* Taking anxiolytics during the study (or in the case of taking them, changing drug or dose during the study).

Where it's running

  • University Jaume I
    Castellon, Castellón, Spain
    Recruiting

Study contacts

  • Principal investigator: Juana María Bretón-López, Lecturer — University Jaume I
  • Study coordinator: Iratxe Alonso-Olea, Phd Student
  • Email: iolea@uji.es
  • Phone: +34 964 38 76 51

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.